NO955110L - Rekombinant stratum corneum chymotryptisk enzym (SCCE) - Google Patents

Rekombinant stratum corneum chymotryptisk enzym (SCCE)

Info

Publication number
NO955110L
NO955110L NO19955110A NO955110A NO955110L NO 955110 L NO955110 L NO 955110L NO 19955110 A NO19955110 A NO 19955110A NO 955110 A NO955110 A NO 955110A NO 955110 L NO955110 L NO 955110L
Authority
NO
Norway
Prior art keywords
scce
stratum corneum
chymotryptic enzyme
corneum chymotryptic
recombinant
Prior art date
Application number
NO19955110A
Other languages
English (en)
Other versions
NO955110D0 (no
NO322728B1 (no
Inventor
Torbjorn Egelrud
Lennart Hansson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO955110D0 publication Critical patent/NO955110D0/no
Publication of NO955110L publication Critical patent/NO955110L/no
Publication of NO322728B1 publication Critical patent/NO322728B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/86—Products or compounds obtained by genetic engineering
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Processing Of Solid Wastes (AREA)
  • Cosmetics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO19955110A 1993-06-18 1995-12-15 Nukleotidsekvens kodende for rekombinant stratum corneum chymotryptisk enzym (SCCE), samt replikerbar ekspresjonsvektor, plasmid, vertscelle, fremgangsmater, diagnostisk middel, sammensetninger og anvendelser derav. NO322728B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK93725A DK72593D0 (da) 1993-06-18 1993-06-18 Rekombinant protein
PCT/IB1994/000166 WO1995000651A1 (en) 1993-06-18 1994-06-20 Recombinant stratum corneum chymotryptic enzyme (scce)

Publications (3)

Publication Number Publication Date
NO955110D0 NO955110D0 (no) 1995-12-15
NO955110L true NO955110L (no) 1996-02-15
NO322728B1 NO322728B1 (no) 2006-12-04

Family

ID=8096824

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19955110A NO322728B1 (no) 1993-06-18 1995-12-15 Nukleotidsekvens kodende for rekombinant stratum corneum chymotryptisk enzym (SCCE), samt replikerbar ekspresjonsvektor, plasmid, vertscelle, fremgangsmater, diagnostisk middel, sammensetninger og anvendelser derav.

Country Status (21)

Country Link
US (2) US5834290A (no)
EP (2) EP0703985B1 (no)
JP (1) JP3542804B2 (no)
KR (1) KR100379207B1 (no)
CN (1) CN100457908C (no)
AT (2) ATE315584T1 (no)
AU (1) AU684518B2 (no)
BR (1) BR9407015A (no)
CA (1) CA2165197C (no)
CZ (1) CZ289600B6 (no)
DE (2) DE69434612T2 (no)
DK (3) DK72593D0 (no)
ES (2) ES2208656T3 (no)
FI (1) FI119027B (no)
HU (1) HU220339B (no)
NO (1) NO322728B1 (no)
PL (1) PL178589B1 (no)
RU (1) RU2160312C2 (no)
SK (1) SK284599B6 (no)
UA (1) UA45314C2 (no)
WO (1) WO1995000651A1 (no)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK72593D0 (da) * 1993-06-18 1993-06-18 Symbicom Ab Rekombinant protein
US5976556A (en) * 1996-06-13 1999-11-02 Active Organics, Inc. Combination of acid protease enzymes and acidic buffers and uses thereof
GB9616139D0 (en) * 1996-08-01 1996-09-11 Grampian Pharm Ltd Veterinary treatments
CN1137677C (zh) * 1997-02-12 2004-02-11 强生消费者公司 丝氨酸蛋白酶和外用类视色素组合物
US5856139A (en) * 1997-03-11 1999-01-05 Incyte Pharmaceuticals, Inc. Proline-rich acidic protein
US6316213B1 (en) * 1997-03-19 2001-11-13 The Board Of Trustees Of The University Of Arkansas Methods for the early diagnosis of ovarian, breast and lung cancer
US6627403B2 (en) * 1997-03-19 2003-09-30 The Board Of Trustees Of The University Of Arkansas Methods for the early diagnosis of ovarian cancer
US6294344B1 (en) * 1997-03-19 2001-09-25 The Board Of Trustees Of The University Of Arkansas Methods for the early diagnosis of ovarian cancer
US5962300A (en) * 1997-03-26 1999-10-05 Incyte Pharmaceuticals, Inc. Human kallikrein
FR2761363B1 (fr) * 1997-03-28 1999-11-26 Oreal Polypeptide purifie de l'epiderme et son utilisation
AU7484198A (en) * 1997-05-12 1998-12-08 Sage Pharmaceuticals, Inc. Topical spray for burn treatment and anti-infection
EP0898962A1 (en) * 1997-08-28 1999-03-03 Becton, Dickinson and Company Transdermal patches and methods for inactivating skin proteases
US6589770B1 (en) * 1997-10-03 2003-07-08 The Procter & Gamble Company Keratinocyte derived protease
CA2305708A1 (en) * 1997-10-03 1999-04-15 The Procter & Gamble Company A keratinocyte derived protease
US6262249B1 (en) 1998-06-23 2001-07-17 Chiron Corporation Pancreatic cancer genes
US20050053983A1 (en) * 1998-11-20 2005-03-10 Fuso Pharmaceutical Industries, Ltd. Novel serine protease BSSP4
SE9900431D0 (sv) * 1999-02-09 1999-02-09 Johan Stenflo Monoklonal antikropp
US6420157B1 (en) * 1999-04-30 2002-07-16 Ortho-Mcneil Pharmaceutical, Inc. Zymogen activation system
US6485957B1 (en) * 1999-04-30 2002-11-26 Ortho-Mcneil Pharmaceutical, Inc. DNA encoding the human serine protease EOS
US6458564B1 (en) * 1999-08-31 2002-10-01 Ortho-Mcneil Pharmaceutical, Inc. DNA encoding the human serine protease T
US6426199B1 (en) * 1999-08-31 2002-07-30 Ortho-Mcneil Pharmaceutical, Inc. Dna
HK1056821B (en) 2000-04-04 2005-03-18 Color Access, Inc. Composition for improving skin lipid barrier function
ATE515940T1 (de) * 2001-02-09 2011-07-15 Torbjoern Egelrud Scce transgene mäuse und deren verwendung als modell für menschliche krankheiten
US7019194B2 (en) 2001-02-09 2006-03-28 Lennart Hansson SCCE modified transgenic mammals and their use as models of human disease
GB0128629D0 (en) * 2001-11-29 2002-01-23 Univ Sheffield Method
RU2230575C2 (ru) * 2002-06-18 2004-06-20 Закрытое акционерное общество "Петроспирт" Антисептическое средство "ахдез 3000"
AU2002952597A0 (en) * 2002-11-11 2002-11-28 Schering-Plough Pty. Limited Topical parasiticide formulations and methods of treatment
RU2235324C1 (ru) * 2003-02-25 2004-08-27 Государственное учреждение Тверская государственная медицинская академия Способ определения казеинолитической активности микроорганизмов при экспресс-диагностике дисбактериоза кишечника
CN100518740C (zh) * 2003-06-06 2009-07-29 阿里克斯股份公司 杂环化合物作为scce抑制剂的制药用途
CA2468651A1 (en) * 2003-06-13 2004-12-13 Eleftherios P. Diamandis Detection of neurodegenerative diseases
EP1716248A1 (en) * 2004-02-03 2006-11-02 Bayer HealthCare AG Diagnostics and therapeutics for diseases associated with kallikrein 7 (klk7)
WO2005085469A2 (en) * 2004-03-09 2005-09-15 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with rho-associated protein kinase 1 (rock1)
US9205080B2 (en) 2006-11-16 2015-12-08 Transderm, Inc. Methods of treating keratin hyperproliferation disorders using mTOR inhibitors
US8476243B2 (en) 2006-12-29 2013-07-02 Transderm, Inc. Methods and compositions for treating keratin hyperproliferative disorders
FR2925312B1 (fr) * 2007-12-19 2016-12-02 Oreal Utilisation cosmetique de proteines de type desmogleine i
US8466335B2 (en) 2010-04-26 2013-06-18 The Procter & Gamble Company Personal care product
US8685309B2 (en) 2010-04-26 2014-04-01 The Procter & Gamble Company Method for making a personal care product
TWI556737B (zh) 2011-02-11 2016-11-11 陶氏農業科學公司 改良的殺蟲劑配方
WO2014117035A1 (en) 2013-01-24 2014-07-31 Transderm, Inc. COMPOSITIONS FOR TRANSDERMAL DELIVERY OF mTOR INHIBITORS
RU2585960C1 (ru) * 2015-02-17 2016-06-10 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт медицины труда" (ФГБНУ "НИИ МТ") Способ определения наследственной предрасположенности к нарушению барьерной функции кожи
JP7108631B2 (ja) 2017-01-06 2022-07-28 パルヴェラ セラピューティクス、インク． ｍＴＯＲ阻害剤の無水組成物およびその使用方法
US20200040103A1 (en) 2018-03-14 2020-02-06 Genentech, Inc. Anti-klk5 antibodies and methods of use
CN108421034A (zh) * 2018-04-24 2018-08-21 济南磐升生物技术有限公司 激肽释放酶7在皮肤创伤愈合中的应用
JP7606209B2 (ja) * 2018-06-08 2024-12-25 ザ ボード オブ リージェンツ オブ ザ ユニヴァーシティ オブ オクラホマ アルツハイマー病および関連状態を処置するためのペプチド治療薬
US11000513B2 (en) 2018-07-02 2021-05-11 Palvella Therapeutics, Inc. Anhydrous compositions of mTOR inhibitors and methods of use
US12252582B2 (en) 2019-08-29 2025-03-18 University Of Delaware Biofunctional thiophene monomers and polymers thereof for electronic biomedical devices
PE20221906A1 (es) * 2019-09-18 2022-12-23 Genentech Inc Anticuerpos anti-klk7, anticuerpos anti-klk5, anticuerpos multiespecificos anti-klk5/klk7 y metodos de uso
BR102020009679A2 (pt) 2020-05-14 2021-11-23 Fundação Universidade Federal Do Abc - Ufabc Anticorpos recombinantes humanos para inibição da calicreína tecidual humana 7 (klk7) e uso em doenças relacionadas ao processo de descamação da pele
GB202018320D0 (en) * 2020-11-20 2021-01-06 Univ Newcastle Methods of producing recombinant complement proteins
JP2024512377A (ja) * 2021-03-12 2024-03-19 ジェネンテック， インコーポレイテッド 抗ｋｌｋ７抗体、抗ｋｌｋ５抗体、多重特異性抗ｋｌｋ５／ｋｌｋ７抗体、及び使用方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4652639A (en) * 1982-05-06 1987-03-24 Amgen Manufacture and expression of structural genes
US4695458A (en) * 1986-02-05 1987-09-22 Krumeich Jorg H Solution of alpha-chymotrypsin
JP3200609B2 (ja) * 1990-12-28 2001-08-20 敏一 中村 上皮細胞増殖促進剤
GB9207288D0 (en) * 1992-04-02 1992-05-13 Unilever Plc Cosmetic composition
RU2036658C1 (ru) * 1992-07-27 1995-06-09 Тихоокеанский научно-исследовательский институт рыбного хозяйства и океанографии Способ лечения инфицированных ран
US5470733A (en) * 1993-06-01 1995-11-28 University Of Maryland Calcium free subtilisin mutants
DK72593D0 (da) * 1993-06-18 1993-06-18 Symbicom Ab Rekombinant protein
AU5435496A (en) * 1995-04-04 1996-10-23 Eli Lilly And Company Amyloid precursor protein protease

Also Published As

Publication number Publication date
US5834290A (en) 1998-11-10
ES2256669T3 (es) 2006-07-16
ATE315584T1 (de) 2006-02-15
CA2165197A1 (en) 1995-01-05
SK284599B6 (sk) 2005-07-01
DE69433280T2 (de) 2004-07-22
US5981256A (en) 1999-11-09
PL312189A1 (en) 1996-04-01
CZ289600B6 (cs) 2002-03-13
HUT74835A (en) 1997-02-28
DE69433280D1 (de) 2003-12-04
ATE252884T1 (de) 2003-11-15
RU2160312C2 (ru) 2000-12-10
CN1128047A (zh) 1996-07-31
EP0703985A1 (en) 1996-04-03
FI956075L (fi) 1996-02-16
NO955110D0 (no) 1995-12-15
HU9503618D0 (en) 1996-02-28
EP1398326A3 (en) 2004-03-31
JP3542804B2 (ja) 2004-07-14
CA2165197C (en) 2009-02-10
WO1995000651A1 (en) 1995-01-05
EP1398326B1 (en) 2006-01-11
HU220339B (hu) 2001-12-28
PL178589B1 (pl) 2000-05-31
JPH08511431A (ja) 1996-12-03
FI119027B (fi) 2008-06-30
AU6935294A (en) 1995-01-17
SK158695A3 (en) 1997-02-05
DK0703985T3 (da) 2004-02-23
DK1398326T3 (da) 2006-05-22
EP0703985B1 (en) 2003-10-29
ES2208656T3 (es) 2004-06-16
KR100379207B1 (ko) 2003-09-26
EP1398326A2 (en) 2004-03-17
DE69434612T2 (de) 2006-10-05
CZ333595A3 (en) 1997-03-12
CN100457908C (zh) 2009-02-04
FI956075A0 (fi) 1995-12-18
AU684518B2 (en) 1997-12-18
DK72593D0 (da) 1993-06-18
BR9407015A (pt) 1996-09-10
DE69434612D1 (de) 2006-04-06
NO322728B1 (no) 2006-12-04
UA45314C2 (uk) 2002-04-15

Similar Documents

Publication Publication Date Title
ATE252884T1 (de) Rekombinantes stratum corneum chymotypisches enzym ( scce)
ATE282087T1 (de) Modifiziertes enzym mit lipolytischer aktivität
AU605124B2 (en) Novel peptide plasminogen activators
TR200000578T2 (tr) Heparanas aktiviteye sahip olan bir polipeptit deşifre eden polinükleotit ve çevrilmiş hücrelerde aynısını izahı.
DE69432818D1 (de) Enzym mit proteaseaktivität
DK0832229T3 (da) CD40L-mutein
WO1998020145A3 (en) Improvements in or relating to starch content of plants
MX9709472A (es) & -amilasa mutante.
ATE317904T1 (de) Überexpression von phytase in hefesystemen
DE69435307D1 (de) Bazillus Thuringiensis und dessen insektizide Proteine
HUP9801638A2 (hu) Kevésbé adszorbeálódó és jobban hidrolizáló proteáz K variánsok
PT83898B (pt) Metodo para a producao de inibidores da trombina a base de proteinas com actividade de hirudina
DE69535696D1 (de) Tripeptidyl-aminopeptidase
NZ527971A (en) Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon
ATE307197T1 (de) An der regenierung von luciferin beteiligtes enzym
FI840104A7 (fi) Yhdistelmä-DNA-ekspressoimisvektoreita, jotka ovat käyttökelpoisia Bacillus- ja muissa isäntäsoluissa.
NO962023L (no) Endotelin-konverterende enzym
ITRM930845A0 (it) Peptide ad attivita' di substrato e/o inibitore dell'enzima transglutaminasi e suo uso in giagnosi e terapia.
HUP9903633A1 (hu) Javított tulajdonságú barstargén

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT POSTBOKS 1003 SENTRUM OSLO, 0

MM1K Lapsed by not paying the annual fees